ORPHA:99715
MASS syndrome
Also known as: Mitral valve-aorta-skeleton-skin syndrome
Publications
6,108,631
Trials
0
Interventional, condition-specific
Researchers
1,104
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
6,108,631 matched papers (3,493,143 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
6,108,631
6,108,631 papers — among the better-studied rare conditions, though still a fraction of common-disease literature (breast cancer: over 700,000). Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
6,108,631 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
3,493,143 in the last 10 years · low confidence
Phrase hits: 400 · MeSH hits: 0
Who's working on it?
1,104
Distinct author names in 200 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Porta M7 papers · 2025
h Department of Functional Neurosurgery , IRCCS Galeazzi Hospital, Tourette Center , Milan , Italy.
Papers in Europe PMC - 02Wang Y7 papers · 2026
Clinical Center for Interstitial Lung Diseases, Beijing Institute of Respiratory Medicine and Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China.
Papers in Europe PMC - 03Albert U4 papers · 2022
d Department of Neuroscience Rita Levi Montalcini, AOU San Luigi Gonzaga , University of Turin , Orbassano , Italy.
Papers in Europe PMC - 04Benatti B4 papers · 2022
a Department of Psychiatry, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico , University of Milan , Milan , Italy.
Papers in Europe PMC - 05Dell'Osso B4 papers · 2022
a Department of Psychiatry, Fondazione IRCCS Cà Granda, Ospedale Maggiore Policlinico , University of Milan , Milan , Italy.
Papers in Europe PMC - 06Galentino R4 papers · 2024
Tourette Center, IRCCS Galeazzi Orthopaedic Institute, 20157 Milan, Italy.
Papers in Europe PMC - 07Gambini O4 papers · 2022
f Department of Health Sciences , University of Milan , Milan , Italy.
Papers in Europe PMC - 08Servello D4 papers · 2025
h Department of Functional Neurosurgery , IRCCS Galeazzi Hospital, Tourette Center , Milan , Italy.
Papers in Europe PMC - 09Amore M3 papers · 2022
IRCCS Ospedale Policlinico San Martino , , , Department Of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health, Section Of Psychiatry, University Of Genoa, Genoa, Italy, Genoa, Italy
Papers in Europe PMC - 10Barki A3 papers · 2021
Department of Urology, Mohamed VI University Hospital Center, Mohamed I University, Oujda, Morocco.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
low confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 40 · after dedupe 39 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 39 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (39)
- isrctn·ISRCTN21343134·Recruiting·Exploring Symprove product for the management of gastroesophageal reflux disease (GORD) symptoms
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15642871·Recruiting·Investigating the role of dietary probiotics on athletic performance and health
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN13207472·No longer recruiting·A two-part study in healthy volunteers to investigate the feasibility of a combined test medicine formulation
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN16150360·Not yet recruiting·Investigating the impact of kefir on metabolic syndrome subjects in an inpatient setting
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30134752·No longer recruiting·Autoprobiotic Enterococcus supplements for the treatment of metabolic syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN26393895·Recruiting·Effects of electronic cigarettes and traditional cigarettes on brain structures
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN17635288·Recruiting·Gut microbial activity, lifestyle factors, and bone metabolism in premenopausal and postmenopausal women
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10073073·Recruiting·A study testing the safety and effects of FB-102 in healthy volunteers
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18042878·Recruiting·Can supplementation of natural Cyclic Glycine-Proline (cGP) improve metabolic health in people with the risk of developing metabolic syndrome?
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15681288·Recruiting·Restoring intestinal symbiosis for efficacy in IBS
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN49366748·No longer recruiting·A phase II study to test the safety and effects of BC-006 Injection in adults with obesity
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12762846·No longer recruiting·Effect of antioxidants on stress, work fatigue, and metabolic syndrome in employees of a private corporation in Mexico City
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN39379437·Recruiting·A study of guselkumab versus risankizumab in participants with moderately to severely active Crohn's Disease
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN30625880·No longer recruiting·Clinical evaluation of the efficacy of a food supplement in improving the regularity of bowel movements
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN11866792·Recruiting·How sourdough bread compared with white bread affects blood sugar, digestion and appetite in adults
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN15093638·No longer recruiting·Effectiveness of oral nutritional supplements and nutrition education for improving growth among underweight preschool children in Kuala Lumpur
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN96628953·Not yet recruiting·Aquatic thermal therapy for enhancing musculoskeletal strength in older adults with age-related progressive loss of muscle mass and strength
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN22936350·Recruiting·A Phase I study evaluating the safety and effects of QX031N in healthy participants, participants with chronic obstructive pulmonary disease and participants with asthma
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN24846895·Recruiting·A study to explore the effect of immunotherapy drug, tebentafusp, on patients with clear cell sarcoma (ultra-rare, aggressive type of soft tissue sarcoma that primarily affects young adults)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10195062·No longer recruiting·Evaluation of the efficacy of a food supplement for subjects with metabolic syndrome
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN47913690·Recruiting·A study looking at whether metformin (a diabetes drug) can prevent weight gain caused by antipsychotics in people experiencing their first episode of psychosis
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN83576037·No longer recruiting·A phase 2, safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy study of a subcutaneous injection of BC-006 and tirzepatide in adults with obesity
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10066959·No longer recruiting·Moderate consumption of a functional wine enriched in polyphenols on markers of metabolic syndrome, antioxidant profile, and oxidative damage
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN12131144·No longer recruiting·We all eat microbes: diet as reservoir of microorganisms that preserve the ecosystem services of the human gastrointestinal microbiota (the μbEat project)
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN18283468·No longer recruiting·A clinical trial to learn more about the absorption of radiolabeled drug LXE408, how the body breaks it down, and how quickly the body gets rid of it in healthy men
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for MASS syndrome — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
("MASS syndrome" OR "Mitral valve-aorta-skeleton-skin syndrome") OR ("MASS" OR "MASS-related")ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"MASS syndrome" OR "Mitral valve-aorta-skeleton-skin syndrome"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is short or not clearly distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
- No Orphanet definition and no Mondo IDs — likely taxonomy scaffolding; confidence capped at low
Ingested 2026-07-27T06:13:12.062Z
